Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page. The old revision tag v3.4.2 was removed and the new v3.4.3 tag added to reflect an update.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No study data or user-facing content is affected.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now displays Revision: v3.4.1 and no longer displays Revision: v3.4.0.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a glossary display option and updated metadata to Revision: v3.4.0, including Last Update Submitted that Met QC Criteria and No FEAR Act Data. Removed the previous QC-related labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a consolidated Locations section listing study sites across multiple regions (US, Australia, Canada, Taiwan, Spain) and removed the old per-country location blocks. The update reorganizes site information on the page to streamline finding participating sites.SummaryDifference1%

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.